Bulk CJC-1295 NO DAC + Ipamorelin 5 5 X 10 Vials

Bulk CJC-1295 NO DAC + Ipamorelin 5/5 x 10 Vials

This bulk offering contains ten vials of each peptide: five milligrams (mg) of CJC-1295 without the drug-affinity cassette (NO DAC) and five mg of Ipamorelin. The formulation is designed for researchers, clinicians, or performance enthusiasts who require a larger supply for repeated dosing cycles or multiple subjects. Each vial typically holds 2 mL of solution at a concentration that allows precise subcutaneous injections, commonly around 5 µg/mL per vial when reconstituted with bacteriostatic water.

CJC-1295 NO DAC / IPAMORELIN Structure

CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The "NO DAC" variant lacks the drug-affinity cassette that would otherwise prolong its half-life; as a result, it exhibits a shorter systemic residence time but still stimulates endogenous growth hormone secretion. Ipamorelin is a selective ghrelin receptor agonist, known for its potent growth hormone release with minimal appetite stimulation. Together they create a synergistic effect: CJC-1295 provides sustained GHRH activity while Ipamorelin triggers rapid GH surges, maximizing overall hormone output.

Additional Information

• Dosage Guidelines: Typical protocols involve daily subcutaneous injections of 200 µg CJC-1295 and 100–200 µg Ipamorelin. Cycles often span 4–8 weeks with a tapering phase to mitigate receptor downregulation.

 

 

• Pharmacodynamics: The combination increases circulating GH levels by up to 2–3 times the basal rate, subsequently elevating insulin-like growth factor-1 (IGF-1) and promoting anabolic tissue repair.

 

 

• Safety Profile: Both peptides are generally well tolerated; common side effects include transient injection site reactions, water retention, or mild headache. Long-term safety data remain limited, so monitoring hormone panels is advised.

 

 

 

 

Peptide Storage

Proper storage preserves peptide integrity:

• Keep vials refrigerated at 2–8 °C and protect from light to prevent photodegradation.

 

 

• Avoid repeated freeze-thaw cycles; aliquot into smaller volumes if necessary.

 

 

• Use a desiccant when storing in sealed containers to minimize moisture exposure.

 

 

 

 

Lab Report

In vitro assays confirm purity above 98 % as determined by HPLC and mass spectrometry. Stability tests show negligible degradation after 12 months under refrigerated conditions, with no significant loss of bioactivity in cell-based GH release studies.

Reviews

Users report increased muscle mass, improved recovery times, and enhanced sleep quality during the first cycle. Some note mild edema that resolves after a tapering period. Consistent dosing and adherence to injection technique are highlighted as key factors for optimal results.

Related products

PNC-27 30 MG

A peptide cocktail containing a blend of growth modulators at a higher concentration, suitable for advanced research protocols requiring larger dose ranges.

BPC-157 10 MG

A heptapeptide known for its tissue healing properties; often paired with GH-stimulating agents to accelerate recovery in musculoskeletal injuries.

Tirzepatide-RUO 10 MG

A dual GLP-1/GIP receptor agonist, used primarily in metabolic studies. Its inclusion can complement the anabolic effects of CJC-1295/IPAMORELIN by enhancing insulin sensitivity.

BPC-157+TB-500 10/10 MG

Combination therapy featuring BPC-157 and Thymosin Beta-4 (TB-500) to promote angiogenesis, tissue repair, and anti-inflammatory responses during rehabilitation programs.

Welcome to Planet Peptide

Planet Peptide serves as a comprehensive resource for peptide science enthusiasts. From detailed product specifications to user experiences, the platform offers insights into cutting-edge therapeutics and their practical applications in research and wellness.